Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Neurochirurgie ; 68(6): 583-588, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35700789

ABSTRACT

BACKGROUND: Mesial temporal lobe epilepsy (MTLE) is a symptomatic epilepsy syndrome clinically characterized by high prevalence, pharmacoresistance, good surgical prognosis and hippocampal sclerosis (HS); however, no singular criteria can be considered sufficient for the MTLE-HS diagnosis. MicroRNAs (miRNAs) are small non-coding molecules that act as important gene-expression regulators at post-transcriptional level. Evidences on the involvement of miRNAs in epilepsy pathogenesis as well as their potential to be employed as biomarkers claim for investigations on miRNAs' applicability as epilepsy diagnosis and prognosis biomarkers. Consequently, the present study aimed to evaluate the applicability of three specific miRNAs as biomarkers of diagnosis and surgical outcomes in adult patients with MTLE-HS. METHOD: Hippocampus, amygdala and blood samples from 20 patients with MTLE-HS were analyzed, 10 with favorable surgical prognosis (Engel I) and 10 with unfavorable surgical prognosis (Engel III-IV). For the control groups, hippocampus and amygdala from necropsy and blood samples from healthy individuals were adopted. The miRNAs expression analysis was performed using Real-Time Quantitative Polymerase Chain Reaction for miRNAs highlighted from microarray as being involved in GABAergic neurotransmission. RESULTS: The miRNAs miR-629-3p, miR-1202 and miR-1225-5p were found to be hyper-expressed in MTLE-HS patients' blood. CONCLUSIONS: Our data suggest the existence of three circulating miRNAs (miR-629-3p, miR-1202 and miR-1225-5p) that could possibly act as additional tools in the set of factors that contribute to MTLE-HS diagnose.


Subject(s)
Epilepsy, Temporal Lobe , MicroRNAs , Adult , Humans , Epilepsy, Temporal Lobe/diagnosis , Epilepsy, Temporal Lobe/genetics , Epilepsy, Temporal Lobe/surgery , Sclerosis/diagnosis , Sclerosis/metabolism , Sclerosis/pathology , Hippocampus/surgery , Hippocampus/metabolism , Hippocampus/pathology , MicroRNAs/genetics , MicroRNAs/metabolism , Biomarkers
2.
Cancer Gene Ther ; 20(9): 499-506, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23887645

ABSTRACT

Glioblastoma (GBM) is one of the most aggressive central nervous system tumors with a patient's median survival of <1 year. Polo-like kinases (PLKs) are a family of serine/threonine kinases that have key roles in cell cycle control and DNA-damage response. We evaluated PLK1, 2, 3 and 4 gene expression in 8 GBM cell lines and 17 tumor samples, and analyzed the effect of the PLK1 inhibition on SF188 and T98G GBM cell lines and 13 primary cultures. Our data showed PLK1 overexpression and a variable altered expression of PLK2, 3 and 4 genes in GBM tumor samples and cell lines. Treatments with nanomolar concentrations of BI 2536, BI 6727, GW843682X or GSK461364 caused a significant decrease in GBM cells proliferation. Colony formation was also found to be inhibited (P<0.05), whereas apoptosis rate and mitotic index were significantly increased (P<0.05) after PLK1 inhibition in both GBM cell lines. Cell cycle analysis showed an arrest at G2 (P<0.05) and cell invasion was also decreased after PLK1 inhibition. Furthermore, simultaneous combinations of BI 2536 and temozolomide produced synergistic effects for both the cell lines after 48 h of treatment. Our findings suggest that PLK1 might be a promising target for the treatment of GBMs.


Subject(s)
Brain Neoplasms/metabolism , Cell Cycle Checkpoints , Cell Cycle Proteins/antagonists & inhibitors , Glioblastoma/metabolism , Protein Kinase Inhibitors/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Proto-Oncogene Proteins/antagonists & inhibitors , Antineoplastic Agents, Alkylating/administration & dosage , Antineoplastic Agents, Alkylating/pharmacology , Brain Neoplasms/drug therapy , Brain Neoplasms/genetics , Cell Cycle Checkpoints/drug effects , Cell Cycle Checkpoints/genetics , Cell Cycle Proteins/genetics , Cell Death/drug effects , Cell Death/genetics , Cell Line, Tumor , Cell Proliferation/drug effects , Dacarbazine/administration & dosage , Dacarbazine/analogs & derivatives , Dacarbazine/pharmacology , Drug Synergism , Glioblastoma/drug therapy , Glioblastoma/genetics , Humans , Protein Kinase Inhibitors/administration & dosage , Protein Serine-Threonine Kinases/genetics , Proto-Oncogene Proteins/genetics , Temozolomide , Tumor Stem Cell Assay , Polo-Like Kinase 1
3.
Chemother Res Pract ; 2013: 593020, 2013.
Article in English | MEDLINE | ID: mdl-23533755

ABSTRACT

Despite advances in neurosurgery and aggressive treatment with temozolomide (TMZ) and radiation, the overall survival of patients with glioblastoma (GBM) remains poor. Vast evidence has indicated that the nuclear factor NF- κ B is constitutively activated in cancer cells, playing key roles in growth and survival. Recently, Dehydroxymethylepoxyquinomicin (DHMEQ) has shown to be a selective NF- κ B inhibitor with antiproliferative properties in GBM. In the present study, the ability of DHMEQ to surmount tumor's invasive nature and therapy resistance were further explored. Corroborating results showed that DHMEQ impaired cell growth in dose- and time-dependent manners with G2/M arrest when compared with control. Clonogenicity was also significantly diminished with increased apoptosis, though necrotic cell death was also observed at comparable levels. Notably, migration and invasion were inhibited accordingly with lowered expression of invasion-related genes. Moreover, concurrent combination with TMZ synergistically inhibited cell growth in all cell lines, as determined by proliferation and caspase-3 activation assays, though in those that express O(6)-methylguanine-DNA methyltransferase, the synergistic effects were schedule dependent. Pretreatment with DHMEQ equally sensitized cells to ionizing radiation. Taken together, our results strengthen the potential usefulness of DHMEQ in future therapeutic strategies for tumors that do not respond to conventional approaches.

4.
Acta Neurochir Suppl ; 114: 117-20, 2012.
Article in English | MEDLINE | ID: mdl-22327675

ABSTRACT

The Monro-Kellie doctrine states that the interior of the cranium is formed of three main components: blood, fluid and cerebral parenchyma. An increase in the volume of one or more components may increase the intracranial pressure (ICP). This doctrine also affirms that the skull cannot be expanded after the closure of the fontanels. Monro and Kellie's theory has been perfected during the last two centuries. This study leads to a new contribution that proves that even adults' consolidated skulls present volumetric changes as a consequence of ICP variations.


Subject(s)
Cerebrovascular Circulation/physiology , Intracranial Hypotension/physiopathology , Intracranial Pressure , Models, Biological , Humans , In Vitro Techniques , Posture , Transducers, Pressure
5.
Braz J Med Biol Res ; 43(8): 794-8, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20658096

ABSTRACT

Zygomycosis is an infection caused by opportunistic fungi of the Zygomycetes class, specifically those from the Mucorales and Entomophthorales orders. It is an uncommon disease, mainly restricted to immunocompromised patients. We report a case of a 73-year-old male patient with a history of fever (39 degrees C) lasting for 1 day, accompanied by shivering, trembling, and intense asthenia. The patient was admitted to the intensive care unit with complex partial seizures, and submitted to orotracheal intubation and mechanical ventilation under sedation with midazolam. The electroencephalogram showed evidence of non-convulsive status epilepticus. There is no fast specific laboratory test that permits confirmation of invasive fungal disease. Unless the physician suspects this condition, the disease may progress rapidly while the patient is treated with broad-spectrum antibiotics. Differential diagnosis between fungal and bacterial infection is often difficult. The clinical presentation is sometimes atypical, and etiological investigation is not always successful. In the present case, the histopathological examination of the biopsy obtained from the right temporal lobe indicated the presence of irregular, round, thick-walled fungi forming papillae and elongated structures of irregular diameter, with no septa, indicative of zygomycete (Basidiobolus). Treatment with liposomal amphotericin B and fluconazole was initiated after diagnosis of meningoencephalitis by zygomycete, with a successful outcome.


Subject(s)
Entomophthorales/isolation & purification , Meningoencephalitis/microbiology , Shock, Septic/microbiology , Zygomycosis/diagnosis , Aged , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Fluconazole/therapeutic use , Follow-Up Studies , Humans , Immunocompromised Host , Male , Meningoencephalitis/diagnosis , Meningoencephalitis/drug therapy , Shock, Septic/diagnosis , Shock, Septic/drug therapy , Treatment Outcome , Zygomycosis/drug therapy
6.
Transplant Proc ; 42(5): 1557-62, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20620474

ABSTRACT

Hepatic ischemia followed by reperfusion (IR) results in mild to severe remote organ injury. Oxidative stress and nitric oxide (NO) seem to be involved in the IR injury. Our aim was to investigate the effects of liver I/R on hepatic function and lipid peroxidation, leukocyte infiltration and NO synthase (NOS) immunostaining in the lung and the kidney. We randomized 24 male Wistar rats into 3 groups: 1) control; 2) 60 minutes of partial (70%) liver I and 2 hours of global liver R; and 3) 60 minutes of partial (70%) liver I and 6 hours of global liver R. Groups 2 and 3 showed significant increases in plasma alanine and aspartate aminotransferase levels and in tissue malondialdehyde and myeloperoxidase contents. In the kidney, positive endothelial NOS (eNOS) staining was significantly decreased in group 3 compared with group 1. However, staining for inducible NOS (iNOS) and neuronal NOS (nNOS) did not differ among the groups. In the lung, the staining for eNOS and iNOS did not show significant differences among the groups; no positive nNOS staining was observed in any group. These results suggested that partial liver I followed by global liver R induced liver, kidney, and lung injuries characterized by neutrophil sequestration and increased oxidative stress. In addition, we supposed that the reduced NO formation via eNOS may be implicated in the moderate impairment of renal function, observed by others at 24 hours after liver I/R.


Subject(s)
Reperfusion Injury/physiopathology , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Immunohistochemistry , Ischemia/physiopathology , Kidney/enzymology , Lung/enzymology , Male , Malondialdehyde/blood , Neutrophils/enzymology , Neutrophils/physiology , Nitric Oxide Synthase/metabolism , Peroxidase/blood , Rats , Rats, Wistar , Reperfusion Injury/pathology
7.
Histol Histopathol ; 25(8): 1017-24, 2010 08.
Article in English | MEDLINE | ID: mdl-20552552

ABSTRACT

Interference by autofluorescence is one of the major concerns of immunofluorescence analysis of in situ hybridization-based diagnostic assays. We present a useful technique that reduces autofluorescent background without affecting the tissue integrity or direct immunofluorescence signals in brain sections. Using six different protocols, such as ammonia/ethanol, Sudan Black B (SBB) in 70% ethanol, photobleaching with UV light and different combinations of them in both formalin-fixed paraffin-embedded and frozen human brain tissue sections, we have found that tissue treatment of SBB in a concentration of 0.1% in 70% ethanol is the best approach to reduce/eliminate tissue autofluorescence and background, while preserving the specific fluorescence hybridization signals. This strategy is a feasible, non-time consuming method that provides a reasonable compromise between total reduction of the tissue autofluorescence and maintenance of specific fluorescent labels.


Subject(s)
Coloring Agents/pharmacology , Histocytological Preparation Techniques/methods , Ammonia , Azo Compounds , Brain , Fluorescence , Fluorescent Antibody Technique , Fluorescent Antibody Technique, Direct , Formaldehyde , Frozen Sections , Histological Techniques , Humans , Indicators and Reagents , Naphthalenes , Nucleic Acid Hybridization , Paraffin Embedding , Photobleaching
8.
Case Rep Med ; 2009: 871365, 2009.
Article in English | MEDLINE | ID: mdl-19718244

ABSTRACT

This case report describes a patient with manic and psychotic symptoms who had a history of neurocysticercosis and presented with an episode of hypertensive hydrocephalus in 2003. Despite her history, she was initially treated for primary psychiatric disease.

9.
Int J Biol Markers ; 23(3): 140-6, 2008.
Article in English | MEDLINE | ID: mdl-18949739

ABSTRACT

Epidermal growth factor receptor (EGFR) gene overexpression has been implicated in the development of many types of tumors, including glioblastomas, the most frequent diffusely infiltrating astrocytomas. However, little is known about the influence of the polymorphisms of EGFR on EGFR production and/or activity, possibly modulating the susceptibility to astrocytomas. This study aimed to examine the association of two EGFR promoter polymorphisms (c.-191C>A and c.-216G>T) and the c.2073A>T polymorphism located in exon 16 with susceptibility to astrocytomas, EGFR gene expression and survival in a case-control study of 193 astrocytoma patients and 200 cancer-free controls. We found that the variant TT genotype of the EGFR c.2073A>T polymorphism was associated with a significantly decreased risk of astrocytoma when compared with the AA genotype [sex- and age-adjusted odds ratio 0.51, 95% confidence interval 0.26-0.98]. No association of the two promoter EGFR polymorphisms (or combinations of these polymorphisms) and risk of astrocytomas, EGFR expression or survival was found. Our findings suggest that modulation of the EGFR c.2073A>T polymorphism could play a role in future therapeutic approaches to astrocytoma.


Subject(s)
Astrocytoma/genetics , Brain Neoplasms/genetics , ErbB Receptors/genetics , Polymorphism, Genetic , Adult , Aged , Alleles , Astrocytoma/ethnology , Brain Neoplasms/ethnology , Brazil , Case-Control Studies , Female , Humans , Male , Middle Aged , Odds Ratio , Treatment Outcome
10.
Hum Exp Toxicol ; 27(12): 919-29, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19273547

ABSTRACT

Glioblastoma multiforme (GBM) is a highly invasive and radioresistant brain tumor. Aiming to study how glioma cells respond to gamma-rays in terms of biological processes involved in cellular responses, we performed experiments at cellular context and gene expression analysis in U343-MG-a GBM cells irradiated with 1 Gy and collected at 6 h post-irradiation. The survival rate was approximately 61% for 1 Gy and was completely reduced at 16 Gy. By performing the microarray technique, 859 cDNA clones were analyzed. The Significance Analysis of Microarray algorithm indicated 196 significant expressed genes (false discovery rate (FDR) = 0.42%): 67 down-regulated and 97 up-regulated genes, which belong to several classes: metabolism, adhesion/cytoskeleton, signal transduction, cell cycle/apoptosis, membrane transport, DNA repair/DNA damage signaling, transcription factor, intracellular signaling, and RNA processing. Differential expression patterns of five selected genes (HSPA9B, INPP5A, PIP5K1A, FANCG, and TPP2) observed by the microarray analysis were further confirmed by the quantitative real time RT-PCR method, which demonstrated an up-regulation status of those genes. These results indicate a broad spectrum of biological processes (which may reflect the radio-resistance of U343 cells) that were altered in irradiated glioma cells, so as to guarantee cell survival.


Subject(s)
Brain Neoplasms/genetics , Gamma Rays , Gene Expression Regulation, Neoplastic/radiation effects , Glioblastoma/genetics , Transcription, Genetic/radiation effects , Brain Neoplasms/pathology , Brain Neoplasms/radiotherapy , Cell Line, Tumor , Cell Survival , Dose-Response Relationship, Radiation , Gene Expression Profiling/methods , Glioblastoma/pathology , Glioblastoma/radiotherapy , Humans , Oligonucleotide Array Sequence Analysis , Radiation Tolerance/genetics , Reproducibility of Results , Reverse Transcriptase Polymerase Chain Reaction , Time Factors
11.
J Neurol Neurosurg Psychiatry ; 77(4): 485-8, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16543527

ABSTRACT

BACKGROUND: Neurocysticercosis is a major cause of epilepsy in developing countries and is endemic in Brazil. To test the hypothesis that the aetiological profile of patients with intractable epilepsy in Brazil includes neurocysticercosis, we conducted a cross sectional study investigating the aetiology of intractable epilepsy. METHODS: A total of 512 patients evaluated at the outpatient clinic for intractable epilepsy at the Ribeirão Preto School of Medicine were included in the survey. Medical intractability was determined on the basis of seizure incidence and severity, and response to appropriate epilepsy management. Neuroimaging included brain CT with non-contrasted and contrasted phases and high resolution MRI. Patients were divided into neurocysticercosis and non-neurocysticercosis groups according to previous diagnostic criteria. RESULTS: The most common epileptogenic lesions were mesial temporal sclerosis (MTS; 56.0%), malformations of cortical development (12.1%), and brain tumours (9.9%). Neuroimaging was normal in 8.7% of patients. Calcifications were found in 27% of patients and were significantly more common in patients with MTS than in those without MTS (p<0.001). Isolated neurocysticercosis was found in only eight patients (1.56%). CONCLUSIONS: These data suggest that neurocysticercosis is an uncommon cause of intractable epilepsy, even in an endemic region such as Brazil, and that it may only represent a coexistent pathology. However, an analysis of our findings reveals that neurocysticercosis was more common in patients with MTS. This finding could suggest either that there is a cause-effect relationship between MTS and neurocysticercosis, or that MTS and neurocysticercosis co-vary with a missing variable, such as socio-economic status.


Subject(s)
Calcinosis/complications , Calcinosis/pathology , Epilepsy/etiology , Neurocysticercosis/complications , Neurocysticercosis/pathology , Adolescent , Adult , Brain Diseases/complications , Brain Diseases/pathology , Child , Cross-Sectional Studies , Demography , Electroencephalography , Epilepsy/diagnosis , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neurocysticercosis/parasitology , Sclerosis/complications , Sclerosis/pathology , Temporal Lobe/pathology
12.
Epilepsy Behav ; 7(2): 316-9, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16043417

ABSTRACT

We report two male patients with medically intractable epilepsy and obsessive-compulsive disorder (OCD) symptoms. Both patients experienced remission of obsessive-compulsive symptoms after surgical treatment of epilepsy. Although the surgeries targeted different brain regions, the two patients had in common unilateral anterior cingulate cortex ablation. On the basis of these observations, we discuss the pathophysiology of OCD symptoms, emphasizing the role of corticosubcortical pathways in their genesis. Our data suggest that surgeries that affect neural loops associated with obsessive-compulsive symptoms can lead to an improvement of OCD; however, the structures responsible for this effect cannot be conclusively determined.


Subject(s)
Compulsive Personality Disorder/etiology , Epilepsy/surgery , Neurosurgical Procedures/adverse effects , Postoperative Complications/physiopathology , Psychosurgery/methods , Adult , Epilepsy/complications , Epilepsy/pathology , Humans , Magnetic Resonance Imaging/methods , Male , Treatment Outcome
13.
J Neurol Neurosurg Psychiatry ; 76(8): 1080-3, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16024883

ABSTRACT

OBJECTIVES: Although chronic calcified neurocysticercosis (NCC) has been considered a major cause of symptomatic epilepsy in developing countries, it can also be an incidental pathological finding in epileptic patients from endemic regions. The mechanisms of brain plasticity occurring in patients with NCC during and after the inflammatory process related to the parasite infection, death, degeneration, and calcification within the host brain might be an independent factor for cognitive impairment in patients with NCC and epilepsy. In order to assess this possibility cognitive performance of patients with mesial temporal lobe epilepsy related to hippocampal sclerosis (MTLE-HS) with and without NCC was investigated through structured neuropsychological testing. METHODS: Cognitive performance of long term MTLE-HS patients with (HS-NCC group, n = 32) and without NCC (HS only, n = 48) was compared. Imbalances between the two groups with respect to clinical, demographic, neuroimaging, and electrophysiological variables were adjusted by linear multiple regression analysis and Bonferroni correction for multiple tests. RESULTS AND CONCLUSIONS: There were no cognitive performance differences between HS-NCC and HS only patients, leading to the conclusion that chronic calcified NCC per se does not aggravate the cognitive performance of patients with long term MTLE-HS.


Subject(s)
Brain Diseases/pathology , Brain Diseases/parasitology , Calcinosis/complications , Calcinosis/pathology , Cognition Disorders/diagnosis , Cognition Disorders/etiology , Epilepsy, Temporal Lobe/etiology , Neurocysticercosis/complications , Neurocysticercosis/pathology , Demography , Electroencephalography , Epilepsy, Temporal Lobe/diagnosis , Female , Headache/diagnosis , Headache/epidemiology , Headache/etiology , Humans , Magnetic Resonance Angiography , Magnetic Resonance Imaging , Male , Neurocysticercosis/cerebrospinal fluid , Neuropsychological Tests , Prospective Studies , Severity of Illness Index , Sinus Thrombosis, Intracranial/epidemiology , Sinus Thrombosis, Intracranial/etiology
14.
Clin Neuropathol ; 23(6): 262-70, 2004.
Article in English | MEDLINE | ID: mdl-15584210

ABSTRACT

BACKGROUND: Although neuroimage and surgical techniques have improved substantially, the prognosis of patients with astrocytic tumors remains unchanged. The purpose of this study was to evaluate the proliferative activity in astrocytic tumors in different grades of malignancy and correlate it to other clinical features. PATIENTS AND METHODS: From archival paraffin-embedded surgical specimens of 40 patients of the Ribeirão Preto Medical School with World Health Organization grade II (n = 10), grade III (n = 5) and grade IV astrocytomas (n = 25), the MIB-1 labeling index (LI) was determined using at least a half of the blocks per case. The results were correlated to the biological behavior of the tumors. The aims of this study were to determine the level of MIB-1 LI values (cut-off) that reflect differences in biological behavior of these tumors, the impact on survival of clinical features such as age, tumor location or extension of surgical removal as well as the adjuvant therapy. RESULTS AND CONCLUSIONS: As expected, a wide range of MIB-1 LI values was disclosed (mean of 2.35% in grade II astrocytomas to 12.28% in glioblastomas). A close relationship was found between MIB-1 LI and survival of patients with astrocytomas according to the histological grade. All but 1 recurrent tumor presented higher MIB-1 LI in the second biopsy, and the mean MIB-1 LI of the patients who died in the immediate postoperative period (n = 7) was higher in comparison to the MIB-1 LI of the respective grade. Postoperative radiation therapy was an important factor that affected the survival of patients with high-grade astrocytomas (p = 0.006). MIB-1 LI cut-off of 3% divided the astrocytomas in 2 groups with significantly different survival (p < 0.001): median survival time of 12 months (low-grade) versus 45 months (high-grade). On the other hand, univariate analysis did not show any correlation between survival and extension of surgical resection (radical versus partial), tumor's location or patient's age at surgery.


Subject(s)
Astrocytoma/metabolism , Biomarkers, Tumor/analysis , Brain Neoplasms/metabolism , Ki-67 Antigen/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Astrocytoma/mortality , Astrocytoma/pathology , Brain Neoplasms/mortality , Brain Neoplasms/pathology , Child , Child, Preschool , Female , Humans , Image Processing, Computer-Assisted , Immunohistochemistry , Male , Middle Aged , Prognosis , Reference Values , Retrospective Studies , Survival Analysis
15.
Neuroradiology ; 46(10): 830-3, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15300344

ABSTRACT

Castleman's disease is an atypical lymphoproliferative disorder that may present as a localized or multicentric form. The involvement of the central nervous system is rare. We describe here a case of Castleman's disease with involvement of the hypothalamus and meninges, presenting as hypopituitarism. Radiological and clinical pathological features are emphasized and a review of the literature is presented.


Subject(s)
Brain/diagnostic imaging , Brain/pathology , Castleman Disease/complications , Hypopituitarism/etiology , Adult , Castleman Disease/diagnostic imaging , Castleman Disease/pathology , Female , Humans , Hypopituitarism/diagnostic imaging , Hypopituitarism/pathology , Radiography
16.
Neurology ; 63(3): 557-60, 2004 Aug 10.
Article in English | MEDLINE | ID: mdl-15304595

ABSTRACT

Studies in animals lacking the cellular prion protein (PrP(c)) gene (Prnp) showed higher neuronal excitability in vitro and increased sensitivity to seizures in vivo. The authors previously reported a rare polymorphism at codon 171 (Asn-->Ser) of human Prnp to be associated with mesial temporal lobe epilepsy related to hippocampal sclerosis. They demonstrated that the same variant allele is also associated with symptomatic epilepsies related to different forms of malformations of cortical development.


Subject(s)
Amino Acid Substitution , Amyloid/genetics , Cerebral Cortex/abnormalities , Epilepsy/genetics , Polymorphism, Single Nucleotide , Protein Precursors/genetics , Adolescent , Adult , Alleles , Apoptosis , Brazil/epidemiology , Cell Division , Cell Movement , Cerebral Cortex/pathology , Child , Congenital Abnormalities/epidemiology , Congenital Abnormalities/genetics , Congenital Abnormalities/pathology , DNA Mutational Analysis , Epilepsy/epidemiology , Epilepsy/pathology , Ethnicity/genetics , Europe/epidemiology , Female , Gene Frequency , Genotype , Humans , Male , Prion Proteins , Prions
17.
Forensic Sci Int ; 139(2-3): 123-34, 2004 Jan 28.
Article in English | MEDLINE | ID: mdl-15040905

ABSTRACT

Degradation of human DNA extracted from forensic stains is, in most cases, the result of a natural process due to the exposure of the stain samples to the environment. Experiences with degraded DNA from casework samples show that every sample may exhibit different properties in this respect, and that it is difficult to systematically assess the performance of routinely used typing systems for the analysis of degraded DNA samples. Using a batch of artificially degraded DNA with an average fragment size of approx. 200 bp a collaborative exercise was carried out among 38 forensic laboratories from 17 European countries. The results were assessed according to correct allele detection, peak height and balance as well as the occurrence of artefacts. A number of common problems were identified based on these results such as strong peak imbalance in heterozygous genotypes for the larger short tandem repeat (STR) fragments after increased PCR cycle numbers, artefact signals and allelic drop-out. Based on the observations, strategies are discussed to overcome these problems. The strategies include careful balancing of the amount of template DNA and the PCR cycle numbers, the reaction volume and the amount of Taq polymerase. Furthermore, a careful evaluation of the results of the fragment analysis and of automated allele calling is necessary to identify the correct alleles and avoid artefacts.


Subject(s)
Clinical Laboratory Techniques/standards , DNA Fingerprinting/standards , DNA Fragmentation , Polymerase Chain Reaction/methods , Tandem Repeat Sequences , Alleles , Cooperative Behavior , DNA/analysis , Europe , Humans , Polymerase Chain Reaction/statistics & numerical data
18.
Neurology ; 61(9): 1204-10, 2003 Nov 11.
Article in English | MEDLINE | ID: mdl-14610121

ABSTRACT

BACKGROUND: Mesial temporal lobe epilepsy related to hippocampal sclerosis (MTLE-HS) is the most common surgically remediable epileptic syndrome. Ablation of the cellular prion protein (PrP(c)) gene (PRNP) enhances neuronal excitability of the hippocampus in vitro and sensitivity to seizure in vivo, indicating that PrP(c) might be related to epilepsy. OBJECTIVE: To evaluate the genetic contribution of PRNP to MTLE-HS. METHODS: The PRNP coding sequence of DNA from peripheral blood cells of 100 consecutive patients with surgically treated MTLE-HS was compared to that from a group of healthy controls adjusted for sex, age, and ethnicity (n = 180). The presence of PRNP variant alleles was correlated with clinical and presurgical parameters as well as surgical outcome. RESULTS: A variant allele at position 171 (Asn-->Ser), absent in controls, was found in heterozygosis (Asn171Ser) in 23% of patients (p < 0.0001). The PRNP genotypes were not correlated with any clinical or presurgical data investigated. However, patients carrying the Asn171Ser variant had a five times higher chance of continuing to have seizures after temporal lobectomy (95% CI 1.65 to 17.33, p = 0.005) than those carrying the normal allele. At 18 months after surgery, 91.8% of patients with the normal allele at codon 171 were seizure free, in comparison to 68.2% of those carrying Asn171Ser (p = 0.005). CONCLUSIONS: The PRNP variant allele Asn171Ser is highly prevalent in patients with medically untreatable MTLE-HS and influences their surgical outcome. The results suggest that the PRNP variant allele at codon 171 (Asn171Ser) is associated with epileptogenesis in MTLE-HS.


Subject(s)
Epilepsy, Temporal Lobe/physiopathology , Epilepsy, Temporal Lobe/surgery , Genetic Variation/genetics , Prions/genetics , Sclerosis/genetics , Adult , Amino Acid Substitution , Brain Chemistry , DNA/analysis , Disease-Free Survival , Epilepsy, Temporal Lobe/complications , Ethnicity/statistics & numerical data , Female , Gene Frequency , Hippocampus/pathology , Humans , Magnetic Resonance Imaging , Male , Odds Ratio , Sclerosis/complications , Sclerosis/pathology , Sex Distribution , Treatment Outcome
19.
Neurology ; 59(2): 266-71, 2002 Jul 23.
Article in English | MEDLINE | ID: mdl-12136068

ABSTRACT

OBJECTIVE: In mesial temporal lobe epilepsy (MTLE), the rate of correct seizure lateralization of ictal semiology and ictal EEG is better for patients with unilateral interictal spikes (UIS) than for patients with bilateral interictal spikes (BIS), possibly due to rapid seizure propagation patterns associated with bilateral epileptogenesis. In this study, the authors investigated if ictal SPECT is a reliable diagnostic test for both UIS and BIS patients. METHODS: Video-EEG recording was used as the gold standard to examine the accuracy of ictal SPECT and its relationship with interictal and ictal EEG. Ninety-three consecutive patients with MTLE associated with hippocampal sclerosis were included in the analysis. Ictal SPECT was considered accurate if two blinded observers independently lateralized the scan correctly. RESULTS: Ictal SPECT correctly lateralized 75 (80.6%) of 93 scans. The rate of correct seizure lateralization was 87.6% for the UIS group and only 55.0% for the BIS group (p = 0.0027). In the EEG epochs, 66.7% of BIS patients vs 43.4% of UIS patients had nonlateralized ictal EEG (p < 0.001). CONCLUSION: The authors conclude that the accuracy of ictal SPECT is worse for MTLE patients with BIS than for those with UIS. The role of ictal SPECT in presurgical evaluation of patients with BIS must be reviewed.


Subject(s)
Epilepsy, Temporal Lobe/diagnostic imaging , Epilepsy, Temporal Lobe/physiopathology , Tomography, Emission-Computed, Single-Photon , Acute Disease , Adult , Epilepsy, Temporal Lobe/etiology , Female , Hippocampus/pathology , Humans , Male , Middle Aged , Sclerosis , Sensitivity and Specificity , Tomography, Emission-Computed, Single-Photon/methods
20.
Rev Soc Bras Med Trop ; 34(5): 487-90, 2001.
Article in Portuguese | MEDLINE | ID: mdl-11600917

ABSTRACT

The clinical manifestations of acquired toxoplasmosis in the immunocompetent patient rarely include localized neurological signs, which are frequent in the immunosuppressed patient (Aids). The objective of this paper is to report the case of a woman with Toxoplasma gondii brain abscess, without an identified cause of immunosuppression.


Subject(s)
Toxoplasmosis, Cerebral/diagnosis , Female , Humans , Immunocompetence , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...